Fig. 6From: Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysisForest plot for pooled grade 3/4 adverse events (AEs) across the combined treatment group and the monotherapy groupBack to article page